Targeted Strategies for Today's Evolving Markets

Mission Investor Relations Previous Client

ChromaDex Corp. (CDXC)

ChromaDex Corp. (CDXC) is a leading developer of phytochemical and botanical reference standards as well as associated intellectual property. Committed to sustainable "green chemistry", the company provides the dietary supplement, food, beverage, nutraceutical and cosmetic industries with the novel ingredients, analytical tools and services to meet product regulatory, quality, efficacy and safety standards.

ChromaDex's diverse array of products are known and used worldwide for research and development and for quality control programs. In addition to providing an unparalleled range of analytical services, contract isolation, microbiological, process development, bioassay services and consulting, the company is currently focusing on clinical studies and the commercialization of its new product, pTeroPure™ pterostilbene.

pTeroPure™ pterostilbene is a 99% pure form of trans-pterostilbene, a compound found in small berries, other small fruits and in the bark and heartwood of some trees. Studies have shown that the phytoalexin may positively impact health conditions such as cardiovascular diseases and cognitive decline, in addition to effecting outcomes of those afflicted with diabetes, blood pressure issues, cancer, and oxidative stress.

Leveraging the most extensive phytochemical catalog in the world, the company has successfully established itself in a consolidating industry by applying scientific precision to its products and services while employing a strong customer centric business model. As the demand for new natural products and phytochemicals continues to grow, the company is well positioned to scale up and supply its core products in the amounts required.

Key Investment Highlights

  • Awarded Frost and Sullivan's "Most Promising Ingredient of the Year" Award
  • Compelling Investment Opportunity with Analyst Price Target of $2.25
  • Increasing Regulatory Activity and Consumer Trends Point to Strong Industry Outlook
  • Rapidly Increasing Revenues in Fast-Growing $150 Billion Nutrition Industry

ChromaDex Corp. Message Board

ChromaDex Corp. Blog


 

< Return to Relationships